Search Results - "Parghane, Rahul"
-
1
PSMA-targeted radioligand therapy in prostate cancer: current status and future prospects
Published in Expert review of anticancer therapy (02-09-2023)Get full text
Journal Article -
2
Peptide Receptor Radionuclide Therapy of Neuroendocrine Tumors
Published in Seminars in nuclear medicine (01-09-2020)“…Peptide receptor radionuclide therapy (PRRT), over the years, has evolved as an important modality in the therapeutic armamentarium of advanced, metastatic or…”
Get full text
Journal Article -
3
Toxicity manifestations encountered in peptide receptor radionuclide therapy setting
Published in Journal of neuroendocrinology (12-11-2024)“…Peptide receptor radionuclide therapy (PRRT) has demonstrated immense promise as a treatment for patients with neuroendocrine tumors (NET) who have…”
Get full text
Journal Article -
4
18F-FDG PET/CT Versus 68Ga-PSMA-11 PET/CT in Evaluation of Distant Metastatic Disease in Recurrent Renal Cell Carcinoma
Published in Journal of nuclear medicine technology (01-09-2023)Get full text
Journal Article -
5
Variable Tracer Avidity and Interlesional Heterogeneity on 18F-FDG, 68Ga-DOTATATE, and 68Ga-DOTA-FAPi-04 PET/CT Imaging in a Single Individual Patient With Progressive Metastatic Medullary Thyroid Carcinoma
Published in Clinical nuclear medicine (01-11-2024)“…In medullary thyroid carcinoma (MTC), distant metastases have few therapeutic options with low success rates and substantial toxicity in many patients,…”
Get full text
Journal Article -
6
Clinical utility of 177Lu‐DOTATATE PRRT in somatostatin receptor‐positive metastatic medullary carcinoma of thyroid patients with assessment of efficacy, survival analysis, prognostic variables, and toxicity
Published in Head & neck (01-03-2020)“…Background The primary aim of this study was to evaluate the therapeutic efficacy and outcome of 177Lu‐DOTATATE peptide receptor radionuclide therapy (PRRT) in…”
Get full text
Journal Article -
7
Long-term outcome of “Sandwich” chemo-PRRT: a novel treatment strategy for metastatic neuroendocrine tumors with both FDG- and SSTR-avid aggressive disease
Published in European journal of nuclear medicine and molecular imaging (01-03-2021)“…Objective The primary aims of this study were to evaluate the long-term outcome of a “sandwich chemo-PRRT (SCPRRT)” regimen with regard to therapeutic response…”
Get full text
Journal Article -
8
Evaluation of Ectopic Kidney Located at the Deep Subcutaneous Region of the Abdominal Wall: Role of Diuretic Renography with 99m Tc-DTPA
Published in Journal of nuclear medicine technology (20-06-2024)“…An ectopic kidney is often found inadvertently during CT, ultrasonography, MRI, or urologic physical examination. Ectopic kidneys usually occur in the pelvis…”
Get full text
Journal Article -
9
Role of Novel Quantitative Imaging Techniques in Hematological Malignancies
Published in PET clinics (01-10-2024)“…Hematological malignancies exhibit a widespread distribution, necessitating evaluation of disease activity over the entire body. In clinical practice, visual…”
Get full text
Journal Article -
10
177 Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor
Published in Clinical nuclear medicine (01-10-2022)“…ABSTRACTThyroid gland and orbit are rare sites of metastases in neuroendocrine tumors. We present an extremely rare case of rectal neuroendocrine tumor with…”
Get full text
Journal Article -
11
Thyroid Incidentaloma on 68Ga-PSMA-11 PET/CT Leading to Detection of Thyroid Metastasis in Metastatic Prostate Carcinoma
Published in Clinical nuclear medicine (01-03-2022)“…68Ga-labeled prostate-specific membrane antigen (PSMA)-11 PET/CT has evolved as the noninvasive imaging modality of choice in prostatic adenocarcinoma to…”
Get full text
Journal Article -
12
-
13
False-Positive 68 Ga-DOTATATE PET/CT Findings in Hereditary Hypophosphatemia-Osteomalacia Mimicking Culprit Lesions of Tumor-Induced Osteomalacia
Published in Journal of nuclear medicine technology (01-03-2023)“…Ga-DOTATATE PET/CT is an important imaging modality for detection of culprit lesions of tumor-induced osteomalacia in clinically symptomatic patients with…”
Get full text
Journal Article -
14
Combined 177Lu‐PSMA‐617 PRLT and abiraterone acetate versus 177Lu‐PSMA‐617 PRLT monotherapy in metastatic castration‐resistant prostate cancer: An observational study comparing the response and durability
Published in The Prostate (01-11-2021)“…Objective The aim of present study was to determine and compare the overall response rates, progression‐free survival (PFS), overall survival (OS), and…”
Get full text
Journal Article -
15
177Lu-DOTATATE PRRT for Multiple Unusual Metastatic Sites in Neuroendocrine Tumor
Published in Clinical nuclear medicine (30-03-2022)“…Thyroid gland and orbit are rare sites of metastases in neuroendocrine tumors. We present an extremely rare case of rectal neuroendocrine tumor with metastases…”
Get full text
Journal Article -
16
Availability of both [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTATATE as PRRT agents for neuroendocrine tumors: can we evolve a rational sequential duo-PRRT protocol for large volume resistant tumors?
Published in European journal of nuclear medicine and molecular imaging (01-04-2020)Get full text
Journal Article -
17
Complimentary Role of [18F]FDG and [18F]NaF-PET/CT in Evaluating Synchronous Thyroid Carcinoma and Parathyroid Adenoma with Brown Tumors
Published in World journal of nuclear medicine (01-09-2024)“…We herein present a patient initially suspected of multiple lytic skeletal metastasis of unknown primary on anatomical imaging. Metabolic imaging by…”
Get full text
Journal Article -
18
Unusual Metastatic Sites and Radioiodine Uptake in Patients of Differentiated Thyroid Carcinoma with Atypical Clinical Presentations: Utilization of 131 I-Whole-Body Scintigraphy with Regional SPECT/CT
Published in World journal of nuclear medicine (01-06-2024)“…Differentiated thyroid carcinoma (DTC) usually is slow growing and carries a good prognosis. It most commonly tends to spread locally to regional lymph nodes…”
Get full text
Journal Article -
19
Cutaneous, Subcutaneous, and Bilateral Adrenal Gland Metastases in Progressive Prostate Carcinoma: Theranostic Potential of 68 Ga-PSMA-11 PET/CT Imaging and 177 Lu-PSMA-617 Therapy
Published in Clinical nuclear medicine (01-06-2024)“…Prostate carcinoma (PC) is the second most common malignant tumor in males globally. The metastatic spread of PC usually involves the pelvic and abdominal…”
Get full text
Journal Article -
20
Combined 177 Lu-PSMA-617 PRLT and abiraterone acetate versus 177 Lu-PSMA-617 PRLT monotherapy in metastatic castration-resistant prostate cancer: An observational study comparing the response and durability
Published in The Prostate (01-11-2021)“…The aim of present study was to determine and compare the overall response rates, progression-free survival (PFS), overall survival (OS), and clinical toxicity…”
Get full text
Journal Article